Beginning Cash: The amount of cash reported by the company on its previous statement.
CytoMed Therapeutics Limited (GDTC) had Beginning Cash of $3.65M for the most recently reported fiscal quarter, ending 2025-12-31.
| Income Statement Financials | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
| Balance Sheet Financials | |
$2.85M |
|
$4.59M |
|
$5.08M |
|
$6.21M |
|
$0.55M |
|
$0.33M |
|
$0.33M |
|
$0.88M |
|
$5.33M |
|
$5.23M |
|
$5.33M |
|
-- |
|
| Cash Flow Statement Financials | |
$-2.88M |
|
$0.72M |
|
$0.16M |
|
|
Beginning Cash |
$3.65M |
$1.63M |
|
$-2.02M |
|
-- |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|